References
Cox AJ, Zhao Y, Ferguson PJ (2017) Chronic recurrent multifocal osteomyelitis and related diseases—update on pathogenesis. Curr Rheumatol Rep 19:18
Donkor J, Zhang P, Wong S, O’Loughlin L, Dewald J, Kok BPC et al (2009) A conserved serine residue is required for the phosphatidate phosphatase activity but not the transcriptional coactivator functions of lipin‑1 and lipin‑2. J Biol Chem 284:29968–29978
Lorden G, Sarjuan-Gardial, de Pablo N, Mena CG et al (2017) Lipin‑2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation. J Exp Med 214(2):511–528
Majeed HA, Kalaawi M, Mohanty D, Teebi AS, Tunjekar MF, Al-Gharbawy F et al (1989) Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr 115:730–734
Ferguson PJ, Chen S, Tayeh MK, Ochoa L, Leal SM, Pelet A et al (2005) Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42:551–557
Açarı C, Bayram M, Yıldız G, Kavukçu S, Soylu A (2023) Effect of MEFV variants on the presentation and clinical course of Henoch-Schonlein purpura in children? Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi 36(3):245–255
Shinar Y, Kosach E, Langevitz P, Zandman-Goddard G, Pauzner R et al (2012) Familial Mediterranean FeVer gene (MEFV) mutations as a modifier of systemic lupus erythematosus. Lupus 21(9):993–998
Ferguson PJ, El-Shanti H (2021) Majeed syndrome: a review of the clinical, genetic and immunologic features. Biomolecules 11:367
Herlin T, Fiirgaard B, Bjerre M (2013) Efficacy of anti-IL‑1 treatment in majeed syndrome. Ann Rheum Dis 72:410–413
Pinto-Fernández ME (2017) Seoane-Reula. Efficacy of treatment withL-1RA in majeed syndrome. Allergol Immunopathol (Madr) 45(1):99–101
Further Reading
Mosaw Z, Madan, Moosawı W et al (2019) Dramatic response of familial majeed syndrome to interleukin‑1 antagonist therapy: case report. Arch Rheumatol 34(3):352–356
Roy N, Zaal A, Hall G et al (2013) Efficacy of anti-IL‑1 treatment in majeed syndrome. Ann Rheum Dis 72(3):410–413
Lorden G, Sanjuan-GarciaI, de Pablo N, Meana C, Alvarez-MiguelI, Perez-Garcia MT et al (2017) Lipin‑2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation. J Exp Med 214:511–528
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
M. Güleç Yazır, E. Durak Ediboğlu, G. Kabadayı, A. Subaşıoğlu, and S. Akar declare that they have no competing interests.
For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case. For images or other information within the manuscript which identify patients, consent was obtained from them and/or their legal guardians.
Additional information
Redaktion
Mike Oliver Becker, Zürich
Paula Hoff, Berlin
Axel Hueber, Nürnberg
Frank Moosig, Neumünster
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Scan QR code & read article online
Rights and permissions
About this article
Cite this article
Güleç Yazır, M., Durak Ediboğlu, E., Kabadayı, G. et al. IL-1 blocking experience in a case with Majeed syndrome diagnosed in adulthood. Z Rheumatol 83, 139–141 (2024). https://doi.org/10.1007/s00393-023-01465-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-023-01465-9